The China-based e-commerce company is set to extend its acquisition activity by buying navigation service AutoNavi in a deal worth about $1.5bn.

In October 2010, 3M New Ventures provided an undisclosed amount to acquire 38% of Perceptive. The groups is understood to have reaped $100m from the sale of its stake to Microsoft, according to an insider on the deal.

Eli Lilly-backed cancer drug developer Cerulean Pharma priced its initial public offering at $7.00, considerably below the range originally set.

The healthcare company made a 52% profit from the sale of its 11% stake, originally acquired in 2012, back to Vodafone for $1.48bn.

The Proteosys-backed pharmaceutical company, formed through a merger last year, is also set to raise $26m from a concurrent private placement to Johnson & Johnson.

The US-based metabolic disease treatment developer has raised $165m since 2002, but plans to raise only $30m when it goes public.

The merger between the two India-based e-commerce companies, which are backed by corporates including IDG and Naspers, values lifestyle retailer Myntra at about $330m.

Cheetah Mobile, which is majority owned by China-based software company Kingsoft and partially by Tencent, plans to float in the US.

IDG's China subsidiary and private equity firm Jafco both achieved partial exits as the education services provider went public raising $137.7m.

The Rakuten-backed, China-based online travel agency has become the latest China-based company to file for an initial public offering in the United States.